Fatal hyponatremia and other metabolic disturbances associated with psychotropic drug polypharmacy

International Journal of Clinical Pharmacology and Therapeutics

Volumn 45, Issue 5, 2007, Pages 289-292

  Vucicevic, Zeljko ^a   Degoricija, V ^a   Alfirevic, Z ^a   Vukicevic Badouin, D ^a  

^a SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

Author keywords

Antipsychotics; Hyponatremia; SIADH

Indexed keywords

ALPRAZOLAM; BIPERIDEN; BROMAZEPAM; DIAZEPAM; FLUPHENAZINE; FUROSEMIDE; GLUCOSE; HALOPERIDOL; INSULIN; OLANZAPINE; PAROXETINE; PSYCHOTROPIC AGENT; SODIUM;

ACUTE PANCREATITIS; ADULT; ANAMNESIS; ANXIETY; ARTICLE; AUTOPSY; BRADYPNEA; BRAIN EDEMA; CASE REPORT; CAUSE OF DEATH; DEPRESSION; DISEASE SEVERITY; GLUCOSE BLOOD LEVEL; HALLUCINATION; HEART ARREST; HOSPITAL ADMISSION; HUMAN; HYPERGLYCEMIA; HYPONATREMIA; HYPOTENSION; INSOMNIA; LONG TERM CARE; MALE; METABOLIC DISORDER; PSYCHOSIS; SCHIZOPHRENIA; SODIUM BLOOD LEVEL; UNCONSCIOUSNESS;

EID: 34248397716     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CPP45289     Document Type: Article

References (20)

1. Ammon HP, Orci L, Steinke J. Effect of chlorpromazine (CPZ) on insulin release in vivo and in vitro in the rat. J Pharmacol Exp Ther. 1973; 187: 423-429.
2. Ananth J, Kolli J, Gunatilake S, Brown S. Atypical antipsychotic drugs, diabetes and ethnicity. Expert Opin Drug Saf. 2005; 4: 1111-1124.
3. Baptista T, Martinez J, Lacruz A et al. Metformin for prevention of weight gain and insulin resistance with olanzapine: a double-blind, placebo-controlled trial. Can J Psychiatry. 2006; 51: 192-196.
4. Crewe HK, Lennard MS, Tucker GT et al. The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes. Brit J Clin Pharmacol. 1992; 34: 262-265.
5. Jackson EK. Vasopressin and other agents affecting the renal conservation of water. In: Brunton LL, Lazo JS, Parker KL (eds). Goodman and Gilman's the pharmacological basis of therapeutics. 11th ed. New York: McGraw-Hill; 2006. p. 771-788.
6. Jacob S, Spinler SA. Hyponatremia associated with selective serotonin-reuptake inhibitors in older adults. Ann Pharmacother. 2006; 40: 1618-1622.
7. Kohen D. Diabetes mellitus and schizophrenia: historical perspective. Br J Psychiatry. 2004; (Suppl.) 47: 64-66.
8. Kubota T, Mivata A. Syndrome of inappropriate secretion of antidiuretic hormone associated with paroxetine. J Anesth. 2006; 20: 126-128.
9. Malhotra AK, Murphy GM Jr, Kennedy JL. Pharmacogenetics of psychotropic drug response. Am J Psychiatry. 2004; 161: 780-796.
10. Matuk F, Kaiyanaraman K. Syndrome of inappropriate secretion of antidiuretic hormone in patients treated with psychotherapeutic drugs. Arch Neurol. 1977; 34: 374-375.
11. Naranjo CA, Busto U, Sellers EM et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol. 1981; 30: 239-245.
12. Newcomer JW, Haupt DW. The metabolic effects of antipsychotic medications. Can J Psychiatry. 2006; 51: 480-491.
13. Palmer BF, Gates JR, Lader M. Causes and management of hyponatremia. Ann Pharmacother. 2003; 37: 1694-1702.
14. Peck V, Shenkman L. Haloperidol-induced syndrome of inappropriate secretion of antidiuretic hormone. Clin Pharmacol Ther. 1979; 26: 442-444.
15. Rider JM, Mauger TF, Jameson JP, Notman DD. Water handling in patients receiving haloperidol decanoate. Ann Pharmacother. 1995; 29: 663-666.
16. Sernyak MJ, Gulanski B, Rosenheck R. Undiagnosed hyperglicemia in patients treated with atypical antipsychotics. J Clin Psychiatry. 2005; 66: 1463-1467.
17. Spigset O, Hedenmalm K. Hyponatremia and the syndrome of inappropriate antidiuretic hormone secretion (SIADH) induced by psychotropic drugs. Drug Safety 1995; 12: 209-225.
18. Twardowschy CA, Bertolucci CB, Gracia CM, Brandao MA. Severe hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone (SIADH) associated with fluoxetine: case report. Arq. 2006; 64: 142-145.
19. Vucicevic Z, Zjacic-Rotkvic V. Chlorpromazine in the etiology and treatment of refractory diabetic ketoacidosis. Pharmaca. 1994; 32: 325-330.
20. Waage C, Carlsson H, Nielsen EW. Olanzapine-induced pancreatitis: a case report. J Pancreas. 2004; 5: 388-391.